Publications

  • Ren S, Ning Y. Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation. American Journal of Physiology - Endocrinology and Metabolism. 2014;306(2):E123-E130.
  • Xu L, Kim JK, Bai Q, et al. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. Molecular Pharmacology. 2013;83(3):648-658.
  • Ren S, Kim JK, Kakiyama G, et al. Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfate. PLoS One. 2014;9(7):e103621.
  • Bai Q, Zhang Z, Xu L, et al. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease. Metabolism Clinical and Experimental. 2012;61(6):836-845.
  • Polyzos SA, Kountouras J, Mantzoros CS. Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease. Metabolism Clinical and Experimental. 2012;61(6):755-758.
  • Sekar M, van Osdol W, Yum S, et al. Drug delivery of biologics: a controlled release strategy. Poster session presented at: IBC’s 17th Annual TIDES Conference; 2015 May 3-6.
  • Sekar M, van Osdol W, Yum S, et al. Controlled delivery depots of liraglutide, a GLP-1 analogue, via subcutaneous injection. Poster session presented at: IBC’s 17th Annual TIDES Conference; 2015 May 3-6.
  • Sekar M, van Osdol W, Yum S, Theeuwes F. Continuous delivery of interferon-α2a via subcutaneous depots. Poster session presented at: American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition; 2012 Oct 14-18.
  • Sekar M, Okumo F, van Osdol W, Tamraz W, Tung D, Sverdrup F. SABER™ formulation for intra-articular delivery of rhGH. Poster session presented at: American Association of Pharmaceutical Scientists 2009 National Biotechnology Meeting; 2009 Jun 21-25.
  • Betschart R, Fleury J, Squires EL, et al. Evaluation of the SABER™ delivery system for the controlled release of the GnRH analog deslorelin for advancing ovulation in mares: effect of gamma radiation. Poster session presented at: 25th International Meeting of the Controlled Release Society; 1998 Jun 21-26; Las Vegas, NV.
  • Fleury J, Squires EL, Betschart R, et al. Evaluation of the SABER™ delivery system for the controlled release of deslorelin for advancing ovulation in the mare: effects of formulation & dose. Poster session presented at: 25th International Meeting of the Controlled Release Society; 1998 June 21-26; Las Vegas, NV.
  • Burns P, Thompson D, Donadue F, et al. Pharmacodynamic evaluation of the SABER™ delivery system for the controlled release of the GnRH analogue deslorelin acetate for advancing ovulation in cyclic mares. Poster session presented at: 24th International Meeting of the Controlled Release Society; 1997 Jun 16-19; Stockholm, Sweden.
  • Donadue FJ, Thompson DL, Burns PJ, et al. Evaluation of the SABER delivery system for the release of GnRH analog deslorelin acetate for advancing ovulation in the mare. Poster session presented at: 15th Annual Meeting of the Equine Nutrition and Physiology Society Meeting; 1997 May 29-31; Fort Worth, TX.